Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.International Chemical Investors Group (ICIG) is set to take over Roche Colorado including the pharmaceutical production facility in Boulder, Colorado.
Subscribe to our email newsletter
Roche‘s Boulder plant, engaged in the production of therapeutic peptide compounds, is equipped with large scale synthetic manufacturing technologies.
The agreement allows ICIG to take over the technical development and small molecule manufacturing capabilities of Roche’s affiliate.
Following the acquisition, Roche’s Boulder site will be re branded as Corden Pharma Colorado, as part of its pharmaceutical business within the Corden Pharma organization.
Roche Chemical Manufacturing head Georg Wiebecke said selling the Boulder site to ICIG will secure a reliable supplier to meet Roche’s demand for commercial scale peptides and other medicinal compounds.